ClinConnect ClinConnect Logo
Search / Trial NCT03840590

Adenoma Detection Rate Using AI System in China

Launched by CHANGHAI HOSPITAL · Feb 12, 2019

Trial Information

Current as of April 29, 2025

Completed

Keywords

Adenoma Detection Rate

ClinConnect Summary

Colorectal cancer is common in China. Most colorectal cancers happen when an adenoma becomes cancerous. Doctors use colonoscopy to look inside the colon and rectum and find adenomas and remove them. Removing adenomas is known to reduce the chances of a person developing colorectal cancers. The ability of colonoscopists finding adenomas varies, and there is a lot of researches into how to improve "adenoma detection rates".

A new AI system, called the CSK endoscopic diagnosis and treatment system has been designed to improve the rate of polyp detection at colonoscopy. Previous tests have sho...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients referred for screening, surveillance, or diagnostic colonoscopy
  • All patients must be able to give informed consent
  • Exclusion Criteria:
  • Patients with any absolute contraindications to colonoscopy
  • Patients with established or suspicion of large bowel obstruction or pseudo-obstruction
  • Patients with known colon cancer or polyposis syndromes
  • Patients with known colonic strictures
  • Patients with known severe diverticular segments (that is likely to impede colonoscope passage)
  • Patients with active colitis (ulcerative colitis, Crohn's colitis, diverticulitis, infective colitis)
  • Patients lacking capacity to give informed consent
  • Pregnancy
  • Patients who are on clopidogrel, warfarin, or other new generation anticoagulants who have not stopped this for the procedure.
  • Patients who are attending for a therapeutic procedure or assessment of a known lesion

About Changhai Hospital

Changhai Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence, the hospital integrates cutting-edge medical technologies and a multidisciplinary approach to patient care. Changhai Hospital actively collaborates with research organizations and healthcare professionals to conduct rigorous clinical trials aimed at developing new treatments and improving patient outcomes. By prioritizing patient safety and ethical standards, the hospital plays a pivotal role in contributing to the advancement of medical knowledge and the enhancement of therapeutic options.

Locations

Shanghai, Shanghai, China

Tianjin, Tianjin, China

Guangzhou, Guangdong, China

Tianjin, Tianjin, China

Patients applied

0 patients applied

Trial Officials

En-Da YU, MD

Principal Investigator

Changhai Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials